About: Overall Survival with Osimertinib in Untreated, EGFR-Mutated Advanced NSCLC

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Overall Survival with Osimertinib in Untreated, EGFR-Mutated Advanced NSCLC Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 21 November 2019

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) artículu científicu espublizáu en payares de 2019 (ast) scientific article published on 21 November 2019 (en) наукова стаття, опублікована 21 листопада 2019 (uk)
publication date	wds:Q91372466-2D0DE1A5-8D6F-4B16-BC43-9F2EECAD7F4D
publication date	2019-11-21 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q91372466-222F8AC4-38F2-4754-92C5-07737C5E7C05
language of work or name	English
author name string	wds:Q91372466-18C7B696-EBAA-42BD-BD74-F8B9BBB56DED wds:Q91372466-26C4453D-F962-4BA2-8DBD-C576AA715445 wds:Q91372466-2B1786AF-AE63-4EFA-B53C-96E77846492E wds:Q91372466-3A242425-318F-4BC7-BFCB-422ECAFE3FDE wds:Q91372466-3B0FD746-5C4F-44CF-AF7E-D9E006DEC885 wds:Q91372466-50751246-B35F-417F-BF40-AF507EB6BD0A wds:Q91372466-54503270-BBA4-475D-A8D7-DD1BEB906A96 wds:Q91372466-57DFF625-FED1-4CF7-AB8E-AE72BBFFA1B5 wds:Q91372466-586F3435-86A0-488D-B540-7B1EE7CA83CC wds:Q91372466-5A489743-15B4-4C17-9FC6-46E5C2D4B02D wds:Q91372466-640849D6-95A3-4CD3-B437-92F01757C421 wds:Q91372466-6A670B22-6948-444D-8304-1C074D6F8683 wds:Q91372466-6CD0DC49-D9EC-4844-AF23-DA475CB7912C wds:Q91372466-71CACFF9-D3D7-4211-B8B9-869DED071247 wds:Q91372466-7792FE55-7746-4E52-B30D-6B1FE036DA8F wds:Q91372466-81BB717B-E89B-40BC-AAB0-F5EBB79AFE05 wds:Q91372466-8312DAFD-05BB-46C8-A470-EBEF07B67189 wds:Q91372466-94B125D6-3729-48FF-8B81-22D5FCC027EC wds:Q91372466-A09D34FE-CBA0-4627-A04F-F3B19B6EFDD8 wds:Q91372466-A6950EEA-C1E7-44A6-88BF-814697D350EF wds:Q91372466-B2A30902-47E1-4847-AA28-5062D509DD55 wds:Q91372466-C87B43F3-555F-4D68-9E96-D1CD4CB7C105 wds:Q91372466-C9A08900-C830-4244-B577-CE6B0DC96D80 wds:Q91372466-CEE5588A-0297-4A56-A72E-DE55EDE7F142 wds:Q91372466-F4EB92F5-E0BA-497F-BE96-DEDDA0BD02B8
author name string	Manuel Cobo Thomas John Ying Cheng Marcello Tiseo Caicun Zhou Jean-Charles Soria Yuichiro Ohe Johan Vansteenkiste Byoung Chul Cho Fumio Imamura David Planchard Takayasu Kurata Suresh S Ramalingam Meng-Chih Lin Thanyanan Reungwetwattana Yuri Rukazenkov Ki Hyeong Lee Matilde Saggese Jhanelle E Gray Riyaz Shah Busyamas Chewaskulyong Alexander Todd Parneet Cheema Rachel Hodge FLAURA Investigators
rdfs:label	Overall Survival with Osimertinib in Untreated, EGFR-Mutated Advanced NSCLC (en) Overall Survival with Osimertinib in Untreated, EGFR-Mutated Advanced NSCLC (nl)
skos:prefLabel	Overall Survival with Osimertinib in Untreated, EGFR-Mutated Advanced NSCLC (en) Overall Survival with Osimertinib in Untreated, EGFR-Mutated Advanced NSCLC (nl)
name	Overall Survival with Osimertinib in Untreated, EGFR-Mutated Advanced NSCLC (en) Overall Survival with Osimertinib in Untreated, EGFR-Mutated Advanced NSCLC (nl)
title	wds:Q91372466-CDADF6A4-D89A-40C7-9B29-888B111F2796
title	Overall Survival with Osimertinib in Untreated, EGFR-Mutated Advanced NSCLC (en)
page(s)	wds:Q91372466-E4CBF600-4DEB-40DA-A599-5A5732AA1A34
page(s)	41-50
instance of	wds:Q91372466-CA6E55BC-495A-4240-AA0C-C383F93E2ED3
instance of	scholarly article
main subject	wds:Q91372466-DC38B248-A5A8-4E91-BDC4-4B0964C1EB74
main subject	non-small-cell lung carcinoma
PubMed ID	wds:Q91372466-CF7783CC-8783-4D3E-AB76-A0AB400F31B9
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/31751012
PubMed ID	31751012
published in	wds:Q91372466-67B017BC-73D5-4B08-AC56-BC1A130067F7
published in	The New England Journal of Medicine
issue	wds:Q91372466-2E59FCAD-5FAC-4F31-8C8C-3CA8C497E60A
volume	wds:Q91372466-ED95F6A7-835D-4759-BC10-4273C857E73A
issue	1
volume	382
DOI	wds:Q91372466-95927212-2781-4B76-B7B6-93D1FA092F3C
DOI	http://dx.doi.org/10.1056/NEJMOA1913662
DOI	10.1056/NEJMOA1913662
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q91372466
is cites work of	Early prediction of resistance to tyrosine kinase inhibitors by plasma monitoring of EGFR mutations in NSCLC: a new algorithm for patient selection and personalized treatment Drug sensitivity and allele-specificity of first-line osimertinib resistance EGFR mutations Identification of Epidermal Growth Factor Receptor Tyrosine-Kinase Mutations in Non-small Cell Lung Cancer: Testing Platform Matters Non-small-cell lung cancer brain metastases and PD-(L)1 immune checkpoint inhibitors Marked synergy by vertical inhibition of EGFR signaling in NSCLC spheroids shows SOS1 is a therapeutic target in EGFR-mutated cancer Canadian consensus: a new systemic treatment algorithm for advanced EGFR-mutated non-small-cell lung cancer Simultaneous targeting of MET overexpression in EGFR mutation-positive non-small cell lung cancer can increase the benefit of EGFR-TKI therapy? Switching from first or second generation EGFR-TKI to osimertinib in EGFR mutation-positive NSCLC Tepotinib plus gefitinib in patients with EGFR-mutant non-small-cell lung cancer with MET overexpression or MET amplification and acquired resistance to previous EGFR inhibitor (INSIGHT study): an open-label, phase 1b/2, multicentre, randomised tria Chemotherapy Plus EGFR-TKI as First-Line Treatment Provides Better Survival for Advanced EGFR-Positive Lung Adenocarcinoma Patients: Updated Data and Exploratory In Vitro Study Targeting the tyrosine kinase inhibitor-resistant mutant EGFR pathway in lung cancer without targeting EGFR? The impact of age and performance status on the efficacy of osimertinib in patients with EGFR T790M-positive non-small cell lung cancer TGFβ2-mediated epithelial-mesenchymal transition and NF-κB pathway activation contribute to osimertinib resistance ROS1-dependent cancers - biology, diagnostics and therapeutics

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 173 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software